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Abstract 
Changes in the muscarinic acetylcholine receptor binding properties in response to in vitro administered 
cholinesterase (ChE) inhibitors were studied in rat brain homogenates. Several anticholinesterases 
(ethopropazine, 1 ,S-bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide, eserine, iso-OMPA and 
DFP) were tested to inhibit specific |5H)(-)quinuclidinyl benzilate ([3HJ(-)QNB) binding to rat brain 
membrane preparations. Under the conditions applied, the relative affinities of these compounds were found 
to decrease in the following sequence: ethopropazine, l,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one 
dibromide, eserine, iso-OMPA. DFP did not affect the specific binding o f [3H](-)QNB in vitro. The K, values 
for the individual drugs were: ethopropazine, I0 ? M; l,S-bis(4-allyldimethylaramoniumphenyl)pentan-3-one 
dibromide, 3.1x10'* M; eserine, 2-IxlO"4 M; iso-OMPA, 10'3 M. The results suggest that certain ChE 
inhibitors might be able to compete with specific ['H](-)QNB binding at the muscarinic receptor. 
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Introduction 
Several studies have demonstrated that the number and pharmacological 
properties of the muscarinic acetylcholine receptors (mAChR) in nervous tissues 
change under various pathological conditions, such as disease (WASTEK and 
YAMAMURA, 1978; RUBERG et al., 1982), chronic administration of drugs (GAZIT et 
al., 1979; NOMURA et al., 1979; EHLERT et al., 1980a, b), or certain in vitro 
circumstances (AGUILAR et al., 1980). For example, the chronic administration of 
cholinesterase (ChE) inhibitors to animals led to behavioral tolerance (OVERSTREET et 
al., 1974). It has been suggested that this phenomenon may result from a decreased 
sensitivity of the mAChR in response to the increased levels of acetylcholine (ACh; 
RUSSEL et al., 1980). In other experiments (EHLERT and KOKKA, 1978; GAZIT et al., 
1979), the chronic administration of organophosphates led to a marked reduction in 
the density of mAChR in several regions of the rat brain, as revealed by the binding 
profile of [3H](-)quinuclidinyl benzilate ([5H](-)QNB). However, there relatively few 
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data are available concerning about the in vitro action of anticholinesterases on 
mAChR in the mammalian nervous system. 
The main goal of the present study was therefore to investigate the in vitro effects 
of some of the most commonly used ChE inhibitors on the mAChR binding in the rat 
brain. 
Materials and Methods 
Male rats (CFY strain) weighing 180-200 g were used. The brains were quickly removed and 
homogenized (10% w / w ) in ice-cold 0 .32 M sucrose containing 0.1 mM EDTA in a glass homogenizer with a 
motor-driven Teflon pestle (6 ,000 rpm). The method used to study the binding o f [ 5 H X - ) Q N B was a 
m o d i f i c a t i o n ( G U L Y A a n d K A S A , 1 9 8 4 ) o f that o f YAMAMURA a n d SNYDER ( 1 9 7 4 ) . B r i e f l y , t h e b i n d i n g a s s a y 
was performed in 50 m M sodium pho sphate bufTer (pH 7.4 at 25 °C) containing 0 .5 nM [ J H ) ( - ) Q N B ( 1 . 1 8 
Tbq mmol ; Radiochemical Centre, Amersham, U K ) in the presence or absence o f various concentrations 
( 1 0 ' " to 10'* M) o f anticholinesterases. A second set was also prepared additionally containing I ц M 
atropine, to determine the specific binding. The binding reaction was initiated by the addition o f 5 0 jil o f 
0.1 % homogenate , and the incubation was allowed to proceed for 120 min at 2 5 °C. The incubation w a s 
terminated by rapid filtration o f the mixture through a Whatman GF/C glass fiber filter. Each filter w a s 
washed with 5 ml o f 5 0 m M sodium phosphate buffer (pH 7.4 at 4 °C) and then air-dried in scintillation vials. 
Ten ml o f scintillation fluid ( 1 0 0 0 ml o f toluene, 150 mg o f POPOP and 4 g o f PPO) was added to each vial. 
The radioactivity was determined with an LKB 1215 Rackbeta II scintillation counter with 4 4 % ef f i c i ency . 
Corrections for quenching were composed via a quench curve prepared by means o f the external standard 
channel ratio method. The specif ic binding o f [ 5 H)(-)QNB was defined as the difference between the total and 
the nonspeci f ic binding o f the radioligand in the presence o f 1 | i M atropine. IC50 and nH va lues were 
determined by indirect Hill ( logit- log) plots o f the inhibition o f the specific ( H](-)QNB binding by ChE 
inhibitors (GraFit 3.0, Erithacus Software, U. K.), and converted to K, values via the equation 
K,=ICJO/( 1 +C/KD), where c is the concentration o f the radiolabeled ligand. Protein concentrations were 
determined by the method o f LowRYet al. (1951) , using bovine serum albumin as standard. 
The fo l lowing ChE inhibitors were used: eserine sulfate, IO-{2-(dimethylamino)propyl]phcnothiazine 
(ethopropazine hydrochloride), l ,5-bis(4-al lyldimethylammoniumphenyl)pentan-3-onc dibromidc, tctraiso-
propyl-pyrophosphoramide ( i so-OMPA), all from Sigma, St. Louis, U S A , and di isopropyl-f luorophosphatc 
(DFP; Fluka A G , Buchs, Switzerland). All drugs were freshly dissolved in 50 mM sodium phosphate bufTer 
(pH 7 . 4 at 25 °C). 
Results 
The anticholinesterase agents were tested for their ability to displace specific 
[3H](-)QNB binding to rat brain homogenate. The most potent inhibitor of specific 
[5H](-)QNB binding among the anticholinesterases tested was ethopropazine (Table 
1). Ethopropazine inhibited specific [5H](-)QNB binding with a K| value of about 10"7 
M, while l,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one dibromide, eserine 
and iso-OMPA had K, values of 3-IxlO"6, 2-lxlO"4 and I0'3 M, respectively. DFP at 
concentrations ranging from 10'" to 10"' M failed to affect mAChR binding. 
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Tabic I: Inhibition of [3H1(-)QNB binding by anticholinesterases. The concentrations required to inhibit 
[ 'H](-)QNB binding to the receptors by 50% (ICso) were determined from log probit plots and 
converted to K, values via the equation K,—ICso/( 1 +C/KD). where c is the concentration o f [ HJ(-)QNB), 
and Kj is its dissociation constant. 
Drags K,(M) "H 
atropine 1 0 ' ° 0.97 
ethopropazine I0-7 0.85 
1,5-bis(4-allyldimethylammoniumphenyl) pentan-3-one dibromide 3.1x10-* 0.70 
eserine 2-lxIO"4 0.80 
iso-OMPA io-5 0.84 
Discussion 
We have shown that, beside their known inhibitory effects on 
acetylcholinesterase (AChE, EC 3.1.1.7), anticholinesterases can inhibit specific 
[3H](-)QNB binding to mAChR as well. Although several reports have previously 
investigated the effects of ChE inhibitors, relatively few of them demonstrate the in 
vitro effects on the binding characteristics of the receptor. GAZIT et al. (1979) showed 
that chronic administration of Tetram reduces the number of mAChR in several areas 
of the rat brain, while UCHIDA et al. (1979) reported a decreased [3H](-)QNB binding 
in the ileum of the rat after DFP treatment. DAWSON and JARROTT (1981), however , 
could not demonstrate changes in the pharmacological properties of the mAChR in the 
brain and ileum as a result of administration of this drug. SIVAM et al. (1983) 
described that in vivo chronic administration of DFP reduces the number of mAChR 
sites without affecting their affinity, but in vitro treatment fails to affect the mAChR 
binding. In contrast, EHLERT and KOKKA (1978) and EHLERT et al. (1980a) reported 
that chronic DFP treatment decreased the [JH](-)QNB binding in the striatum; 
however, they emphasized that this decrease was not due to a direct effect of DFP on 
the mAChR, since no inhibition of binding was produced by high concentrations of 
DFP added in vitro. 
In our experiments, DFP did not influence the specific binding of [5H](-)QNB in 
vitro, but another organophosphorus compound examined, iso-OMPA, did have a 
slight effect. The ChE inhibitors which compete with the binding of [3H](-)QNB in 
vitro were ethopropazine, l,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one 
dibromide and eserine. The most potent of these was ethopropazine, which is in good 
agreement with earlier reports of its weak atropine-like effect (SILVER, 1974). 
ChE inhibitors are widely used in physiological and pharmacological experiments 
in order to detect the effects of ACh electrophysiologically. SZERB and SOMOGYI 
(1973) were able to show that, when the AChE activity of rat cortical slices was 
inhibited with eserine, the release of ACh evoked by electrical stimulation was 
slightly depressed. As our results reveal, this may be due to the direct competitive 
effect of the anticholinesterase drug on the pre- and postsynaptic mAChR of cortical 
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cholinergic neurons and draws attention to the limits of its applicability in 
physiological experiments. 
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